147 related articles for article (PubMed ID: 34213738)
1. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.
Loza-Huerta A; Milo E; Picones A; Hernández-Cruz A; Luis E
Pharmacol Rep; 2021 Dec; 73(6):1744-1753. PubMed ID: 34213738
[TBL] [Abstract][Full Text] [Related]
2. Cell-Based Thallium-Influx Fluorescence Assay for Kv10.1 Channels.
Durán-Pastén ML; Luis E
Methods Mol Biol; 2024; 2796():97-103. PubMed ID: 38856897
[TBL] [Abstract][Full Text] [Related]
3. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.
Valdés-Abadía B; Morán-Zendejas R; Rangel-Flores JM; Rodríguez-Menchaca AA
Eur J Pharmacol; 2019 Jul; 855():262-266. PubMed ID: 31082369
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the K
Barriga-Montoya C; Huanosta-Gutiérrez A; Reyes-Vaca A; Hernández-Cruz A; Picones A; Gómez-Lagunas F
Pflugers Arch; 2018 Mar; 470(3):491-503. PubMed ID: 29218452
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human Ether-à-go-go related gene screening assays based on IonWorks Quattro and thallium flux.
Bridal TR; Margulis M; Wang X; Donio M; Sorota S
Assay Drug Dev Technol; 2010 Dec; 8(6):755-65. PubMed ID: 20658944
[TBL] [Abstract][Full Text] [Related]
7. Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
Na W; Ma B; Shi S; Chen Y; Zhang H; Zhan Y; An H
Biochem Pharmacol; 2020 Aug; 178():114089. PubMed ID: 32533968
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone.
Meléndez TA; Huanosta-Gutiérrez A; Barriga-Montoya C; González-Andrade M; Gómez-Lagunas F
Pflugers Arch; 2020 Jan; 472(1):75-87. PubMed ID: 31897736
[TBL] [Abstract][Full Text] [Related]
9. Expanding the pharmacological profile of κ-hefutoxin 1 and analogues: A focus on the inhibitory effect on the oncogenic channel K
Moreels L; Peigneur S; Yamaguchi Y; Vriens K; Waelkens E; Zhu S; Thevissen K; Cammue BPA; Sato K; Tytgat J
Peptides; 2017 Dec; 98():43-50. PubMed ID: 27578329
[TBL] [Abstract][Full Text] [Related]
10. Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.
Huang XP; Mangano T; Hufeisen S; Setola V; Roth BL
Assay Drug Dev Technol; 2010 Dec; 8(6):727-42. PubMed ID: 21158687
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel purpurealidin analogs and evaluation of their effect on the cancer-relevant potassium channel KV10.1.
Moreels L; Bhat C; Voráčová M; Peigneur S; Goovaerts H; Mäki-Lohiluoma E; Zahed F; Pardo LA; Yli-Kauhaluoma J; Kiuru P; Tytgat J
PLoS One; 2017; 12(12):e0188811. PubMed ID: 29220359
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K
Toplak Ž; Merzel F; Pardo LA; Peterlin Mašič L; Tomašič T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445705
[TBL] [Abstract][Full Text] [Related]
13. A new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.
Titus SA; Beacham D; Shahane SA; Southall N; Xia M; Huang R; Hooten E; Zhao Y; Shou L; Austin CP; Zheng W
Anal Biochem; 2009 Nov; 394(1):30-8. PubMed ID: 19583963
[TBL] [Abstract][Full Text] [Related]
14. Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.
Zou B; Yu H; Babcock JJ; Chanda P; Bader JS; McManus OB; Li M
Assay Drug Dev Technol; 2010 Dec; 8(6):743-54. PubMed ID: 21158688
[TBL] [Abstract][Full Text] [Related]
15. APETx4, a Novel Sea Anemone Toxin and a Modulator of the Cancer-Relevant Potassium Channel K
Moreels L; Peigneur S; Galan DT; De Pauw E; Béress L; Waelkens E; Pardo LA; Quinton L; Tytgat J
Mar Drugs; 2017 Sep; 15(9):. PubMed ID: 28902151
[TBL] [Abstract][Full Text] [Related]
16. Gating Modulation of the Tumor-Related Kv10.1 Channel by Mibefradil.
Gómez-Lagunas F; Carrillo E; Pardo LA; Stühmer W
J Cell Physiol; 2017 Aug; 232(8):2019-2032. PubMed ID: 27255432
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent membrane potential assay for drug screening on Kv10.1 channel: identification of BL-1249 as a channel activator.
Gómez-Herrera MA; Patlán E; Estrada-Garrido A; Hernández-Cruz A; Luis E
Front Pharmacol; 2023; 14():1238503. PubMed ID: 37554982
[TBL] [Abstract][Full Text] [Related]
18. A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells.
Weaver CD; Harden D; Dworetzky SI; Robertson B; Knox RJ
J Biomol Screen; 2004 Dec; 9(8):671-7. PubMed ID: 15634793
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay.
Li Q; Rottländer M; Xu M; Christoffersen CT; Frederiksen K; Wang MW; Jensen HS
Anal Biochem; 2011 Nov; 418(1):66-72. PubMed ID: 21782781
[TBL] [Abstract][Full Text] [Related]
20. IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology.
Golden AP; Li N; Chen Q; Lee T; Nevill T; Cao X; Johnson J; Erdemli G; Ionescu-Zanetti C; Urban L; Holmqvist M
Assay Drug Dev Technol; 2011 Dec; 9(6):608-19. PubMed ID: 21561375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
